Laboratories Nexelis Canada Inc.

Doing business as Pairimmune Part of Nexelis Group Inc.

UEI
MBEZLEGWHUN5
CAGE
L0MC2
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Website
iqvia.com
Founded
1982
Employees
50K-100K
Estimated annual revenue
$10B+
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Laboratories Nexelis Canada Inc.

Laboratories Nexelis Canada Inc., doing business as Pairimmune, is a specialty laboratory providing services like assay development, bioanalytical testing, and immunology support for pharmaceutical innovation. Nexelis, a Q² Solutions Company, is registered as a for-profit corporate entity to receive federal awards.

Pairimmune has received several prime contract awards from the Department of Health and Human Services (HHS) to support the federal COVID-19 response. These include a $14.7 million firm-fixed-price definitive contract from the HHS Office of the Assistant Secretary for Preparedness and Response to provide high throughput SARS-CoV-2 binding antibody immunoassay testing of clinical samples from COVID-19 vaccine trials and assay development for emerging variants. Additionally, Pairimmune was awarded a $14.56 million purchase order from the same agency to establish high throughput immunoassay capability and test human serum samples related to the pandemic. Pairimmune also received a $204,000 purchase order from the National Institutes of Health National Institute on Drug Abuse to acquire SARS-CoV-2 pseudoparticles for variant research. None of these HHS contract awards involved set-asides, and Pairimmune served as the prime contractor leveraging its immunology and infectious disease testing expertise.

Quick answers

What is Laboratories Nexelis Canada Inc.'s UEI?

Laboratories Nexelis Canada Inc.'s Unique Entity ID (UEI) in SAM.gov is MBEZLEGWHUN5.

What is Laboratories Nexelis Canada Inc.'s CAGE code?

Laboratories Nexelis Canada Inc.'s CAGE code is L0MC2.

What is Laboratories Nexelis Canada Inc.'s primary NAICS code?

Laboratories Nexelis Canada Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Is Laboratories Nexelis Canada Inc. registered in SAM.gov?

Laboratories Nexelis Canada Inc.'s SAM.gov registration expired on August 26, 2025.

Who is Laboratories Nexelis Canada Inc.'s parent company?

Laboratories Nexelis Canada Inc. is part of Nexelis Group Inc.

What is Laboratories Nexelis Canada Inc.'s most recent federal award?

Laboratories Nexelis Canada Inc.'s most recent federal contract award is High throughput sars-COV-2 binding antibody immunoassay for testing of clinical samples and variant assessment (75A50122C00013), from Office of the Assistant Secretary for Preparedness and Response, on January 1, 2022.

On GovTribe

See Laboratories Nexelis Canada Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors